Results 131 to 140 of about 20,748 (167)

Moving forward from spleen response as an endpoint in randomized controlled trials in myelofibrosis. [PDF]

Haematologica
Van Dijck R, Schnog JB, Te Boekhorst PAW.   +2 more
europepmc   +1 more source

Sweet's syndrome with Koebner phenomenon triggered by G-CSF as a preleukemic manifestation in a patient with primary myelofibrosis: a case report. [PDF]

Front Med (Lausanne)
Zhang Z, Zhou D, Liu Y, Meng L, Ji B.
europepmc   +1 more source

Successful Neutrophil Engraftment with Continued Ruxolitinib in Cord Blood Transplantation. [PDF]

Blood Cell Ther
Nagano T, Kondo T, Hiyama R, Ikeda D, Hayashino K, Inoue Y, Ueno M, Ueda Y, Kubota S, Kobayashi H, Seike K, Fujiwara H, Asada N, Ennishi D, Fujii K, Fujii N, Matsuoka KI, Maeda Y.   +17 more
europepmc   +1 more source

Triple Endoscopic Hemostatic Therapy for Life Threatening Duodenal Variceal Bleed. [PDF]

ACG Case Rep J
Hamarsheh S, Khalid MU, Siddiki H.
europepmc   +1 more source

Hereditary spherocytosis concomitant with JAK2V617F-positive primary myelofibrosis: a case report. [PDF]

Front Oncol
Qiu CE, Lei L, Jiang G, Huang X, Li Y.
europepmc   +1 more source

Myelofibrosis

, 2013
openaire   +1 more source

Momelotinib for myelofibrosis. [PDF]

Aust Prescr
europepmc   +1 more source

Myelofibrosis

, 1978
openaire   +1 more source